Experienced in Autonomic Neuropathy

Esko J. Wiltshire

Coast And Hutt Valley, 
Wellington, WGN, NZ 
Experienced in Autonomic Neuropathy
Coast And Hutt Valley, 
Wellington, WGN, NZ 
OverviewLocationsClinical Research

Overview

Esko Wiltshire practices in Wellington, New Zealand. Mr. Wiltshire is rated as an Experienced expert by MediFind in the treatment of Autonomic Neuropathy. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, DICER1 Syndrome, and Diabetic Ketoacidosis.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Autonomic Neuropathy.

Gender
Male

Locations

Coast And Hutt Valley, Wellington, WGN, New Zealand
Other Locations
Dunedin, OTA, New Zealand
Health New Zealand Lakes, Rotorua, BOP, New Zealand
Christchurch, CAN, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2
An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty
An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty
Enrollment Status: Completed
Publish Date: June 02, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

64 Total Publications

The KiwiDiab First National Paediatric Diabetes Benchmarking Audit: A Report on Children and Adolescents With Diabetes in Aotearoa New Zealand 2023.
The KiwiDiab First National Paediatric Diabetes Benchmarking Audit: A Report on Children and Adolescents With Diabetes in Aotearoa New Zealand 2023.
Journal: Journal of paediatrics and child health
Published: June 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wiltshire's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile